DCSIMG

Durkan urges quick introduction of Meningitis B vaccine

Pictured (from left to right) is Meningitis Now founder Steve Dayman MBE, Chief Executive of Meningitis Now Sue Davie and Foyle MP Mark Durkan.

Pictured (from left to right) is Meningitis Now founder Steve Dayman MBE, Chief Executive of Meningitis Now Sue Davie and Foyle MP Mark Durkan.

SDLP Foyle MP Mark Durkan hosted a briefing event at Westminster this week for the charity Meningitis Now which called on the government to publish details of when the new Meningitis B vaccine (Bexsero) will be given to all babies on the NHS.

The call comes 100 days after the Department of Health announced that the vaccine is being recommended for inclusion in the National Immunisation Programme.

The briefing event also acknowledged the important role that MPs – including Mark Durkan – played in the Beat it Now! campaign to bring in the vaccine.

The Foyle MP said: “One of our greatest responsibilities is ensuring that all our children and young people have the healthiest starts to life, which is why I backed the Beat it Now! vaccine campaign.

“We have an opportunity to prevent a disease which kills or maims many children and we need to keep it high on the health agenda.

“We need to ensure the quick introduction of the Meningitis B vaccine and make it available to all babies on the NHS without delay.”

Meningitis Now also used the reception to outline its policy priorities for the coming year, including promoting early diagnosis; funding research into prevention and helping shape national policy on after-care.

MPs met with Meningitis Now founder Steve Dayman MBE, who began the meningitis movement in the UK after losing his son Spencer to the disease in 1982.

He said: “I want to thank Mark Durkan for his continued support for the introduction of the vaccine and for taking time to meet people personally affected by meningitis.”

Meningitis Now launched its campaign to bring in the B vaccine in January 2013. On 21 March this year, the government announced that its vaccine committee – the JCVI – had recommended the vaccine for inclusion in the national immunisation programme, subject to price negotiations with vaccine manufacturer Novartis.

No further detail has been published by the Department of Health on the negotiations, the timetable for introduction or plans for roll-out.

Meningitis Now will continue its Beat it Now! campaign until the vaccine is introduced. Join the campaign at www.MeningitisNow.org/beat-it-now

 

Comments

 
 

Back to the top of the page